Explore

Iterate

Vision

Cato Research

Cato Research has merged with SMS-oncology forming CATO SMS, a fully integrated global company, delivering innovative strategies and robust solutions based on over 30 years of background in regulatory insight, therapeutic experience, and operational expertise.

Industries

Headquarters

Durham, United States

Employees

201-500

Links

Org chart

Mark A. Goldberg

Executive Chairman

Collapse

Christopher S. Brennan

Chief Administrative Officer & General Counsel

President, Consulting Business Unit

President, Biometrics

David J. Godwin

Chief Revenue Officer

Raymond Hoffmans

Head Integration Management Office

Heschi H. Rotmensch

Chief Medical Officer

Richard Shimota

Chief Financial Officer

Chief Regulatory Officer

Philine Van Den Tol

President, Clinical Trial Operations

VP, Quality

Teams

View all

Leadership Team

11 members

CEO and Executive Team

6 members

Discover similar companies

Amphastar Pharmaceuticals

Rancho Cucamonga, United States

Walgreens Boots Alliance

Deerfield, United States

Acreage Holdings

Post IPO Debt • New York, United States

Eli Lilly

Series E • Indianapolis, United States

CONMED

Post IPO Debt • Utica, United States

Bristol-Myers Squibb

Lawrence Township, United States

AbbVie

North Chicago, United States

Vanda Pharmaceutical

Post IPO Equity • Washington, United States

Prescient Healthcare Group

Private Equity • Jersey City, United States

Viatris

Pittsburgh, United States

Catalent

Venture • Franklin Township, United States

ALLIANCE FOR MULTISPECIALTY RESEARCH, LLC

Knoxville, United States

Two candidates

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.